Sensitive Periods in Early Flavor Learning
1 other identifier
interventional
79
1 country
1
Brief Summary
Flavor is the primary dimension by which young children determine food acceptance. However, children are not merely miniature adults since sensory systems mature postnatally and their responses to certain tastes differ markedly from adults. Moreover, emerging research has revealed that there are sensitive periods during infancy such that early flavor experiences serve to modify later responses to flavors and foods. The proposed study aims to investigate this important issue by using as a model system a class of infant formulas which are hydrolyzed protein based and thus have very pronounced and distinctive flavors which are unpalatable to older-aged infants and adults. This research was initiated because of anecdotal reports by pediatricians that although it is easy to introduce this type of formula to infants during the first months of life, it becomes extremely difficult to do so later in infancy. Indeed, recent studies in the investigators' laboratory provided the first experimental demonstration that infants younger than 4 months of age willingly accept substantial amounts of, and satiate while feeding, a novel, protein hydrolysate formula. In marked contrast, infants older than 4 months reject the protein hydrolysate formula and this rejection occurs within the first minute of a feed, a finding that strongly suggests the sensory qualities of the formula are responsible, at least in part, for this rejection. Moreover, this rejection is not evident when the investigators test older-aged infants with other unfamiliar, but non-hydrolysate, formulas. In other words, the rejection appears to be in response to a particular component or components of protein hydrolysate formulas. This shift in acceptability can be ameliorated by prior exposure. That is, if these formulas are introduced to infants within the first few months of life and are fed continuously, they remain highly acceptable throughout infancy and early childhood. These observations implicate a sensitive period during development, occurring somewhere before 4 months of age, during which exposure to a formula, which is unpalatable to adults and infants over 4 months of age without exposure, renders it acceptable and presumably palatable. To the investigators' knowledge, this is the clearest example of a sensitive period in the development of responses to foods and flavors in humans thus far identified. There is a paucity of information on whether and how the composition of formulas fed to infants influences their short-term feeding behaviors during the first few months of life. The primary objective of this longitudinal study is to determine the period during early infancy when exposure to the casein-hydrolysate formula, Nutramigen, renders it acceptable during later infancy. The study also aims to determine how early sensory experiences with formula impact upon food acceptance during infancy (8-9 months of age) and childhood. The investigators will also explore how variation in the genes that encode for taste receptors influence preferences for foods and other behaviors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable healthy
Started Nov 2006
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2006
CompletedFirst Submitted
Initial submission to the registry
October 12, 2009
CompletedFirst Posted
Study publicly available on registry
October 14, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2010
CompletedOctober 3, 2012
October 1, 2012
3.5 years
October 12, 2009
October 2, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
infants' intake, length of feeding and patterning of feeding of Nutramigen relative to Enfamil (infant-led feeding condition)
0.5-8.5 months
Secondary Outcomes (6)
infant growth (weight and length)
0.5 to 8.5 months of life
maternal perceptions of infant enjoyment of feeding
8.5 months
infants' exploration of toys as a function of scent
9 months
infants' intake of foods as a function of flavor and chemical composition
8 months and 2-3 years
infants' temperament and behavioral development
0.5 months -2years
- +1 more secondary outcomes
Study Arms (6)
Group EEEEEEE
ACTIVE COMPARATORInfant is fed Enfamil from 0.5-7.5 months of life
Group ENEEEEE
EXPERIMENTALInfant is fed Enfamil during 0.5-1.5 months of life, Nutramigen from 1.5-2.5 months of life and then Enfamil 2.5-7.5 of life.
Group EENEEEE
EXPERIMENTALInfant is fed Enfamil 0.5-2.5 months of life, Nutramigen from 2.5-3.5 months of life and then Enfamil from 3.5 to 7.5 months of life
Group EEENEEE
EXPERIMENTALInfant is fed Enfamil from 0.5-3.5 months of life, Nutramigen from 3.5-4.5 months of life and then Enfamil from 4.5-7.5 months of life.
Group ENNNEEE
EXPERIMENTALInfant if fed Enfamil from month 0.5-1.5 months of life, Nutramigen from 1.5 to 3.5 months of life and then Enfamil again 3.5-7.5 months of life.
Group NNNNNNN
EXPERIMENTALInfant is fed Nutramigen from 0.5-7.5 months of life.
Interventions
Nutramigen, protein hydrolysate formula, fed to infants as sole formula source during specified times during the first 8.5 months of life
Enfamil, milk-based formula, fed as formula source during first 8.5 months of life
Eligibility Criteria
You may qualify if:
- Healthy, term infants of any racial background
- Infants may be of either sex
- Infants must be 2 weeks of age
- Infants must be exclusively feeding a cow's milk-based formula
- Mothers must be over 18 years of age
You may not qualify if:
- Infants who were preterm
- Infants who have medical conditions that interfere with feeding or eating
- No major complications during pregnancy or at birth
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Monell Chemical Senses Centerlead
- National Institutes of Health (NIH)collaborator
Study Sites (1)
Monell Chemical Senses Center
Philadelphia, Pennsylvania, 19104, United States
Related Publications (3)
Mennella JA, Lukasewycz LD, Castor SM, Beauchamp GK. The timing and duration of a sensitive period in human flavor learning: a randomized trial. Am J Clin Nutr. 2011 May;93(5):1019-24. doi: 10.3945/ajcn.110.003541. Epub 2011 Feb 10.
PMID: 21310829RESULTMennella JA, Ventura AK, Beauchamp GK. Differential growth patterns among healthy infants fed protein hydrolysate or cow-milk formulas. Pediatrics. 2011 Jan;127(1):110-8. doi: 10.1542/peds.2010-1675. Epub 2010 Dec 27.
PMID: 21187303RESULTMennella JA, Trabulsi JC, Papas MA. Effects of cow milk versus extensive protein hydrolysate formulas on infant cognitive development. Amino Acids. 2016 Mar;48(3):697-705. doi: 10.1007/s00726-015-2118-7. Epub 2015 Oct 26.
PMID: 26497857DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Julie A Mennella, PhD
Monell Chemical Senses Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Member
Study Record Dates
First Submitted
October 12, 2009
First Posted
October 14, 2009
Study Start
November 1, 2006
Primary Completion
May 1, 2010
Study Completion
June 1, 2010
Last Updated
October 3, 2012
Record last verified: 2012-10